(WVVA) West Virginia enjoys enormous satisfaction with a proportion of 20 generic drug manufacturers to fix prices on more than 100 different drugs.
According to Attorney Patrick Morrisey, the lawsuit also nominates 15 senior executives.
“Breaches of anti-pollution are encouraging consumers and, in this case, disrupting those in urgent need of prescription drugs,” said Morrisey.
The litigation concerns medicines used to treat cancer, diabetes, depression, epilepsy, HIV, and other medical conditions. Morrisey said that the chief executives “met during lunches, cocktail parties and golf tours,” as well as frequent communication via phone and email. ”
The lawsuit was filed in the US District Court in Connecticut. It seeks damages, civil penalties and action to restore competition.
Click here to view the content.
Below is the full press release issued by Attorney General WV Patrick Morrisey.
Attorney General Morrisey Sues Teva, Mylan and 18 Types of Drug Maker
CHARLESTON – West Virginia Attorney General Patrick Morrisey who filed a suit alleging that some of the largest varieties of drug manufacturers were around the country, including Mylan Pharmaceuticals, a conspiracy by Teva Pharmaceuticals and one another because 20 manufacturers had engage a broad scheme to inflate prices and manipulate manually, reduce competition. and unduly restrict trade for more than 100 different drug types.
The lawsuit, given by 44 Attorney General, nominated 15 senior individual executive defendants in the heart of the alleged conspiracy responsible for sales, marketing, pricing and operations, including James Nesta, Vice President of Sales in Mylan.
“The allegations we have included in the complaint are illegal and those involved in this type of conspiracy must be accountable,” said Attorney General Morrisey. “Breaches of anti-pollution are encouraging consumers and, in this case, it has an impact on people in urgent need of prescribed drugs.” T
The practice alleged that 20 of the nation's generic drug makers are engaged in a broad, coordinated and systematic campaign to break prices, set prices, distribute markets and close tenders for more. more than 100 different drugs. This alleged collusion included an interconnected network of industrial executives who met during lunch, cocktail parties and golf tours, as well as frequent communication through phone calls, text messages and emails.
The drugs involved are billions of sales dollars in the United States, and the alleged schemes increased prices affecting the health insurance market and individuals who have to pay artificially inflated prices for their prescribed drugs.
Drugs include depression, diabetes, cancer, epilepsy, multiple sclerosis, HIV, deficiency hyperactivity disorder and many other conditions.
The law, filed in the US District Court in the Connecticut District, seeks damages, civil penalties and acts from the court to restore competition to the generic drugs market.
Other pharmaceutical companies named as defenders are Sandoz Inc .; Actavis Holdco US Inc.; Actavis Pharma Inc.; Amneal Pharmaceuticals Inc.; Apotex Corp. .; Aurobindo Pharma U.S. Inc.; Breckenridge Pharmaceutical Inc .; Dr. Laboratories Inc Reddy; Glenmark Pharmaceuticals Inc .; Greenstone LLC; Lannett Company Inc; Lupine Pharmaceuticals Inc.; Par Pharmaceutical Companies Inc; Pfizer Inc.; Taro Pharmaceuticals USA Inc.; Upsher-Smith Laboratories LLC; Wockhardt USA LLC; and Zydus Pharmaceuticals (USA) Inc. t
West Virginia entered the complaint led by Connecticut with Alabama, Alaska, Colorado, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Missouri, Missouri Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington and Wisconsin.